Pharmanutra S.p.A.

Hematology and Iron Deficiency

Clinical research activity is centered on iron deficiency, with attention to restoring hemoglobin levels and improving iron repletion in affected patients, particularly women.

  • Iron-deficient women
  • Hemoglobin normalization
  • Iron replacement therapy

The sponsor’s therapeutic interest is directed toward oral approaches used in the management of iron deficiency and related anemia.

Comparative Iron Therapy

Research includes comparison of Sucrosomial® Iron with Ferric Maltol, reflecting interest in treatments used to address iron deficiency anemia and support correction of low hemoglobin.

  • Oral iron formulations
  • Ferric maltol
  • Sucrosomial® Iron

The focus remains on tolerability and effectiveness within the therapeutic area of iron supplementation.

Women’s Health

The funded research activity is directed toward female patients with iron deficiency, placing emphasis on a population frequently affected by reduced iron stores and anemia.

  • Women’s iron deficiency
  • Anemia management
  • Hematologic support

This area reflects clinical interest in therapies relevant to nutritional deficiency and blood health in women.

Gastrointestinal Iron Absorption

Interest extends to oral iron delivery and the clinical use of formulations designed to improve iron absorption while addressing tolerability concerns associated with treatment.

  • Iron absorption
  • Gastrointestinal tolerability
  • Oral supplementation

These topics align with therapeutic development in nutritional hematology and supportive care for iron-deficient patients.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study comparing Sucrosomial Iron and Ferric Maltol treatment for women with iron deficiency

    Recruiting

    1 1 1 1
    Investigated diseases:
    Spain